CR6731A - Nueva forma de sal y polimorfos - Google Patents

Nueva forma de sal y polimorfos

Info

Publication number
CR6731A
CR6731A CR6731A CR6731A CR6731A CR 6731 A CR6731 A CR 6731A CR 6731 A CR6731 A CR 6731A CR 6731 A CR6731 A CR 6731A CR 6731 A CR6731 A CR 6731A
Authority
CR
Costa Rica
Prior art keywords
polymorphes
salt
new form
refers
present
Prior art date
Application number
CR6731A
Other languages
English (en)
Inventor
Ann Basford Patricia
Blaise Hodgson Paul
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005200A external-priority patent/GB0005200D0/en
Priority claimed from GB0015900A external-priority patent/GB0015900D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of CR6731A publication Critical patent/CR6731A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Abstract

Se refiere a una nueva sal util en terapia. Mas especificamente, la presente invencion se refiere al mesilato de 4-amino-6,7-dimetoxi-2-(5-metanosulfonamido-1,2,3,4-tetrahidroisoquinol-2-il)-5(2-piridil)quinazolina, a procedimientos para su preparacion, a sus usos y a composiciones que lo contienen. La presente unvencion tambien se refiere a nuevos polimorfos no hidratados de la base libre.
CR6731A 2000-03-03 2002-08-19 Nueva forma de sal y polimorfos CR6731A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0005200A GB0005200D0 (en) 2000-03-03 2000-03-03 New salt form
GB0015900A GB0015900D0 (en) 2000-06-28 2000-06-28 New salt form

Publications (1)

Publication Number Publication Date
CR6731A true CR6731A (es) 2004-03-11

Family

ID=26243792

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6731A CR6731A (es) 2000-03-03 2002-08-19 Nueva forma de sal y polimorfos

Country Status (40)

Country Link
US (1) US6683085B2 (es)
EP (1) EP1268468B1 (es)
JP (1) JP3857919B2 (es)
KR (1) KR100496089B1 (es)
CN (1) CN1214029C (es)
AP (1) AP2002002611A0 (es)
AR (1) AR029482A1 (es)
AT (1) ATE253570T1 (es)
AU (1) AU779118B2 (es)
BG (1) BG106869A (es)
BR (1) BR0108910A (es)
CA (1) CA2398963C (es)
CR (1) CR6731A (es)
CZ (1) CZ20022858A3 (es)
DE (1) DE60101157T2 (es)
DK (1) DK1268468T3 (es)
EA (1) EA004748B1 (es)
EE (1) EE200200496A (es)
ES (1) ES2208565T3 (es)
GE (1) GEP20043364B (es)
HK (1) HK1053655A1 (es)
HN (1) HN2001000036A (es)
HR (1) HRP20020718A2 (es)
HU (1) HUP0300006A3 (es)
IL (1) IL150634A0 (es)
IS (1) IS6441A (es)
MA (1) MA26876A1 (es)
MX (1) MXPA02008665A (es)
NO (1) NO20024195L (es)
NZ (1) NZ519672A (es)
OA (1) OA12186A (es)
PE (1) PE20011225A1 (es)
PL (1) PL365070A1 (es)
PT (1) PT1268468E (es)
SI (1) SI1268468T1 (es)
SK (1) SK12282002A3 (es)
TN (1) TNSN01034A1 (es)
TR (1) TR200302130T4 (es)
UA (1) UA72311C2 (es)
WO (1) WO2001064672A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
US7163696B2 (en) 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
DE10223913A1 (de) * 2002-05-29 2003-12-11 Bayer Cropscience Ag Verfahren zur Herstellung spezifischer Kristallmodifikationen polymorpher Substanzen
GB0221582D0 (en) * 2002-09-17 2002-10-23 Pfizer Ltd Method of treatment
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2005089804A2 (en) * 2004-03-16 2005-09-29 Pfizer Limited Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
CN101584696A (zh) * 2008-05-21 2009-11-25 上海艾力斯医药科技有限公司 包含喹唑啉衍生物的组合物及制备方法、用途
CN105596301A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914114A (en) 1984-05-28 1990-04-03 Merck Patent Gesellschaft Mit Breschrankter Haftung 3-[4-(4-phenyl-1,2,3,6-tetrahydro-1-pyridyl)butyl]-5-hydroxy-indole methanesulfonate having sedating and anti-parkinsonism properties
AU594512B2 (en) * 1986-09-16 1990-03-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Hydroxy indole derivatives
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
SI1268468T1 (en) 2004-04-30
WO2001064672A1 (en) 2001-09-07
IS6441A (is) 2002-06-25
TR200302130T4 (tr) 2004-01-21
US6683085B2 (en) 2004-01-27
AU779118B2 (en) 2005-01-06
ES2208565T3 (es) 2004-06-16
NZ519672A (en) 2004-06-25
DE60101157T2 (de) 2004-09-02
TNSN01034A1 (fr) 2005-11-10
EE200200496A (et) 2004-02-16
UA72311C2 (uk) 2005-02-15
EP1268468B1 (en) 2003-11-05
DK1268468T3 (da) 2004-02-09
AR029482A1 (es) 2003-07-02
CA2398963A1 (en) 2001-09-07
CN1214029C (zh) 2005-08-10
KR100496089B1 (ko) 2005-06-17
BG106869A (bg) 2002-12-29
AP2002002611A0 (en) 2002-09-30
HUP0300006A2 (en) 2003-05-28
US20020010188A1 (en) 2002-01-24
DE60101157D1 (de) 2003-12-11
NO20024195D0 (no) 2002-09-03
JP2003525289A (ja) 2003-08-26
EP1268468A1 (en) 2003-01-02
PE20011225A1 (es) 2001-12-08
CN1432010A (zh) 2003-07-23
IL150634A0 (en) 2003-02-12
AU3588801A (en) 2001-09-12
KR20020080463A (ko) 2002-10-23
GEP20043364B (en) 2004-03-10
MA26876A1 (fr) 2004-12-20
BR0108910A (pt) 2002-12-24
CZ20022858A3 (cs) 2003-09-17
EA200200826A1 (ru) 2003-02-27
CA2398963C (en) 2006-10-24
PL365070A1 (en) 2004-12-27
SK12282002A3 (sk) 2003-10-07
NO20024195L (no) 2002-09-03
ATE253570T1 (de) 2003-11-15
HK1053655A1 (en) 2003-10-31
OA12186A (en) 2006-05-09
JP3857919B2 (ja) 2006-12-13
PT1268468E (pt) 2004-01-30
EA004748B1 (ru) 2004-08-26
HRP20020718A2 (en) 2004-02-29
MXPA02008665A (es) 2003-02-24
HN2001000036A (es) 2001-07-09
HUP0300006A3 (en) 2006-01-30

Similar Documents

Publication Publication Date Title
DE60106954D1 (de) Resorcin-derivate
DK1404331T3 (da) Sustained release-formuleringer af oxymorphon
BRPI0316438B8 (pt) uso de eritropoietina em doenças cardíacas
HN2001000277A (es) PIRROLO [2,1 - a] DIHIDROISOQUINOLINAS
DK1294353T3 (da) Anvendelse af en (R) -enantiomer af liponsyre i kosmetiske og dermatologiske sammensætninger
BR0109272A (pt) Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos
CR7182A (es) Benzoilsufanamidas y sulfonilbenzamidinas que se usan como agentes antitumorales
HN2001000224A (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
BR0114059A (pt) Derivados de resorcinol
SG152257A1 (en) Topical preparation containing ambroxol
HN2002000150A (es) Agentes antibacteriano
ATE288747T1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
BR9912327A (pt) Inibidores da uroquinase
CR6731A (es) Nueva forma de sal y polimorfos
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
BR9809071A (pt) Agentes farmacológicos
BR9910539A (pt) Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
BR0009211A (pt) Derivados de resorcinol
BR0210912A (pt) Compostos e composições como inibidores de catepsina
UY26426A1 (es) Nuevos compuestos
BR0012291A (pt) Fenoxifluorpirimidinas
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
BR0009194A (pt) Composição do resorcinol
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)